|Description||TC-O 9311 is a GPR139 agonist.|
|B0084-284853||10 mg||$198||In stock|
|Brife Description||GPR139 agonist|
|Synonyms||TC-O 9311; TC-O-9311; TC-O9311; 2-(3,5-Dimethoxybenzoyl)-N-(naphthalen-1-yl)hydrazinecarboxamide|
Ibandronate (< 100 μM) inhibits growth of both prostate cancer cell lines (LNCaP and PC-3) in a dose dependent manner.
SSM 3 trifluoroacetate
SSM 3 trifluoroacetate is a potent furin inhibitor (EC50 = 54 nM) which blocks furin-dependent cell surface processing of anthrax protective antigen-83 in vitro...
Astragalus polysaccharide is one kind of biological macromolecule extracted from Astragalus. It has antiviral activities.
BI-44847 is a synthetic bio-active chemical had been in phase II clinical trials for the treatment of type 2 diabetes.
MK-0493 is a novel, potent, and selective agonist of the melanocortin receptor 4 (MC4R), one of the best-validated genetic targets and considered one of the mo...
Cgp 21833 has a thiocarbonylamides structure and it is a potent antifilarial agent under laboratory research stage.
Ritobegron ethyl hydrochloride
Ritobegron is a potential Bladder selectivity of the novel β₃-agonist.
PPNDS is a potent and selective P2X1 receptor antagonist (pKB = 7.43 in rat vas deferens). PNDS is approximately 50-fold less selective for P2Y1R and does not i...